Zydis® Orally Disintegrating Tablet (ODT) vs. Standard Tablets (ST)
Catalent’s proprietary Zydis® ODT platform is backed by a large number of clinical studies. This infographic provides a high level summary of studies comparing Zydis ODT against traditional oral tablets. Factors addressed include bioavailability, safety, side effects, speed /pharmacokinetics, variability, specificity, patient preference, taste, compliance, efficacy and outcomes. Specific case studies using selegiline and desmopressin are used to highlight these findings.